$66.7 Million is the total value of DSC Advisors, L.P.'s 31 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 162.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CVS | Buy | CVS HEALTH CORP | $10,593,274 | +9.4% | 153,237 | +17.6% | 15.88% | +87.9% |
ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $9,104,950 | +12.7% | 62,534 | +0.0% | 13.65% | +93.6% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,668,000 | -3.6% | 100,000 | +8.1% | 13.00% | +65.5% |
ABT | New | ABBOTT LABS | $4,515,063 | – | 41,415 | +100.0% | 6.77% | – |
EHTH | Buy | EHEALTH INC | $3,055,200 | +69.6% | 380,000 | +97.4% | 4.58% | +191.2% |
TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $2,334,300 | +46.5% | 310,000 | +72.2% | 3.50% | +151.6% |
BMRN | New | BIOMARIN PHARMACEUTICAL INCput | $2,167,000 | – | 25,000 | +100.0% | 3.25% | – |
KMPH | New | ZEVRA THERAPEUTICS INCcall | $671,670 | – | 131,700 | +100.0% | 1.01% | – |
V | Buy | VISA INC | $306,349 | +30.0% | 1,290 | +23.4% | 0.46% | +122.8% |
MA | Buy | MASTERCARD INCORPORATEDcl a | $298,515 | +32.1% | 759 | +22.0% | 0.45% | +127.4% |
ADBE | New | ADOBE SYSTEMS INCORPORATED | $261,121 | – | 534 | +100.0% | 0.39% | – |
ACN | New | ACCENTURE PLC IRELAND | $250,876 | – | 813 | +100.0% | 0.38% | – |
KMPH | New | ZEVRA THERAPEUTICS INC | $250,410 | – | 49,100 | +100.0% | 0.38% | – |
CRM | Buy | SALESFORCE INC | $250,132 | +18.8% | 1,184 | +12.3% | 0.38% | +103.8% |
ORCL | New | ORACLE CORP | $228,772 | – | 1,921 | +100.0% | 0.34% | – |
NFLX | New | NETFLIX INC | $228,614 | – | 519 | +100.0% | 0.34% | – |
HBI | New | HANESBRANDS INCcall | $227,000 | – | 50,000 | +100.0% | 0.34% | – |
BRKB | New | BERKSHIRE HATHAWAY INC DELcl b new | $214,148 | – | 628 | +100.0% | 0.32% | – |
New | ENHABIT INC | $115,000 | – | 10,000 | +100.0% | 0.17% | – | |
New | VIVID SEATS INC | $79,200 | – | 10,000 | +100.0% | 0.12% | – | |
New | COMSOVEREIGN HLDG CORP | $38,475 | – | 22,500 | +100.0% | 0.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CVS HEALTH CORP | 39 | Q3 2023 | 21.2% |
MICROSOFT CORP | 38 | Q3 2023 | 2.9% |
APPLE INC | 37 | Q3 2023 | 2.7% |
META PLATFORMS INC | 37 | Q3 2023 | 1.6% |
UNITEDHEALTH GROUP INC | 37 | Q3 2022 | 1.5% |
ORACLE CORP | 35 | Q3 2023 | 0.6% |
INTERNATIONAL BUSINESS MACHS | 33 | Q3 2022 | 0.6% |
ALPHABET INC | 32 | Q3 2023 | 16.0% |
ALPHABET INC | 32 | Q3 2023 | 2.6% |
SALESFORCE INC | 30 | Q3 2023 | 0.9% |
View DSC Advisors, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BioScrip, Inc. | March 12, 2015 | 1,842,241 | 2.7% |
TARRAGON CORPSold out | February 25, 2009 | 0 | 0.0% |
OGLEBAY NORTON CO /NEW/Sold out | September 29, 2006 | 0 | 0.0% |
JORGENSEN EARLE M CO /DE/ | August 08, 2005 | 2,444,200 | 5.0% |
AFFIRMATIVE INSURANCE HOLDINGS INC | June 15, 2005 | 1,159,699 | 7.8% |
VESTA INSURANCE GROUP INCSold out | December 30, 2004 | 0 | 0.0% |
HANGER ORTHOPEDIC GROUP INC | November 08, 2004 | 1,103,900 | 5.1% |
View DSC Advisors, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View DSC Advisors, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.